Cigna (CI) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CI Analyst Ratings

Moderate Buy

13 Buy

6 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Cigna

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$6,337.93

▲(32.18% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $6,337.93 with a high forecast of $7,237.70 and a low forecast of $5,423.60. The average price target represents a 32.18% change from the last price of $4,795.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4445":"$4,445","7238":"$7,238","5143.25":"$5,143.3","5841.5":"$5,841.5","6539.75":"$6,539.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7237.70338491,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6337.925731833333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5423.6020197,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.42K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4445,5143.25,5841.5,6539.75,7238],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4961.2,5136.315644993077,5311.431289986153,5486.546934979231,5661.662579972308,5836.778224965385,6011.893869958461,6187.009514951538,6362.125159944615,6537.240804937692,6712.356449930769,6887.472094923846,7062.587739916923,{"y":7237.70338491,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4961.2,5067.101979371795,5173.0039587435895,5278.905938115385,5384.807917487179,5490.709896858974,5596.611876230769,5702.513855602564,5808.415834974358,5914.317814346154,6020.219793717948,6126.121773089743,6232.023752461539,{"y":6337.925731833333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4961.2,4996.769386130769,5032.338772261538,5067.908158392307,5103.477544523077,5139.046930653846,5174.616316784615,5210.185702915384,5245.755089046153,5281.3244751769225,5316.8938613076925,5352.463247438462,5388.032633569231,{"y":5423.6020197,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5152.583,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4446.398,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4909.085,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4867.453,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4592.122,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4879.902,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4647.311,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4929.116,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5098.199,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4813.366,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4967.513,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4768.614,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4961.2,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$7,238

Average Price Target$6,338

Lowest Price Target$5,424

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Jessica Tassan

Piper Sandler

$6,919.77

Buy

44.31%

Upside

Reiterated

10/23/26

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Merck & Company (NYSE: MRK) and US Physical Therapy (NYSE: USPH)

Ben Hendrix

RBC Capital

$6,302.6

Buy

31.44%

Upside

Reiterated

10/07/26

RBC Capital Remains a Buy on Cigna (CI)

Lance Wilkes

Bernstein

$7,125.49→$7,237.7

Buy

50.94%

Upside

Reiterated

10/05/26

Bernstein Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

$6,545.73

Buy

36.51%

Upside

Reiterated

10/02/26

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)

Unknown Analyst

Leerink Partners

Not Ranked

Leerink Partners

$5,610.62

Hold

17.01%

Upside

Reiterated

10/01/26

Cigna (CI) Gets a Hold from Leerink Partners

Michael Wiederhorn

Oppenheimer

$6,826.26

Buy

42.36%

Upside

Reiterated

10/01/26

Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)

Elizabeth Anderson CFA

Evercore ISI

$5,423.6

Hold

13.11%

Upside

Reiterated

10/01/26

Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)

Kevin Fischbeck

Bank of America Securities

$7,069.38

Buy

47.43%

Upside

Reiterated

10/01/26

Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)

Andrew Mok CFA

Barclays

$5,797.64

Hold

20.91%

Upside

Reiterated

10/01/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Charles Rhyee

TD Cowen

$6,321.3

Buy

31.83%

Upside

Reiterated

09/30/26

Wall Street Analysts Are Bullish on Top NA Picks

Stephen Baxter

Wells Fargo

$5,741.54

Hold

19.74%

Upside

Reiterated

09/30/26

Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)

Erin Wright

Morgan Stanley

$6,751.45

Buy

40.80%

Upside

Reiterated

09/29/26

Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361

David Windley

Jefferies

$6,283.9→$5,741.54

Hold

19.74%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

$6,545.73→$5,984.66

Buy

24.81%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

$6,358.71→$6,583.13

Buy

37.29%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Jessica Tassan

Piper Sandler

$6,919.77

Buy

44.31%

Upside

Reiterated

10/23/26

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Merck & Company (NYSE: MRK) and US Physical Therapy (NYSE: USPH)

Ben Hendrix

RBC Capital

$6,302.6

Buy

31.44%

Upside

Reiterated

10/07/26

RBC Capital Remains a Buy on Cigna (CI)

Lance Wilkes

Bernstein

$7,125.49→$7,237.7

Buy

50.94%

Upside

Reiterated

10/05/26

Bernstein Sticks to Their Buy Rating for Cigna (CI)

David S Macdonald

Truist Financial

$6,545.73

Buy

36.51%

Upside

Reiterated

10/02/26

Analysts Offer Insights on Healthcare Companies: Cigna (NYSE: CI), Wave Life Sciences (NASDAQ: WVE) and Regeneron (NASDAQ: REGN)

Unknown Analyst

Leerink Partners

Not Ranked

Leerink Partners

$5,610.62

Hold

17.01%

Upside

Reiterated

10/01/26

Cigna (CI) Gets a Hold from Leerink Partners

Michael Wiederhorn

Oppenheimer

$6,826.26

Buy

42.36%

Upside

Reiterated

10/01/26

Analysts Are Bullish on Top NA Stocks: Cigna (CI), Millrose Properties Inc Class A (MRP)

Elizabeth Anderson CFA

Evercore ISI

$5,423.6

Hold

13.11%

Upside

Reiterated

10/01/26

Analysts Offer Insights on NA Companies: Cigna (NYSE: CI), Hartford Insurance (NYSE: HIG) and Health In Tech, Inc. Class A (NASDAQ: HIT)

Kevin Fischbeck

Bank of America Securities

$7,069.38

Buy

47.43%

Upside

Reiterated

10/01/26

Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Alphabet Class A (NASDAQ: GOOGL) and Cigna (NYSE: CI)

Andrew Mok CFA

Barclays

$5,797.64

Hold

20.91%

Upside

Reiterated

10/01/26

Barclays Sticks to Its Hold Rating for Cigna (CI)

Charles Rhyee

TD Cowen

$6,321.3

Buy

31.83%

Upside

Reiterated

09/30/26

Wall Street Analysts Are Bullish on Top NA Picks

Stephen Baxter

Wells Fargo

$5,741.54

Hold

19.74%

Upside

Reiterated

09/30/26

Analysts Offer Insights on NA Companies: Factset Research (NYSE: FDS), Cigna (NYSE: CI) and Hormel Foods (NYSE: HRL)

Erin Wright

Morgan Stanley

$6,751.45

Buy

40.80%

Upside

Reiterated

09/29/26

Cigna: Buy Rating Reiterated as Specialty Strength Seen Offsetting PBM Headwinds; Price Target Maintained at $361

David Windley

Jefferies

$6,283.9→$5,741.54

Hold

19.74%

Upside

Downgraded

08/03/26

Cigna downgraded to Hold from Buy at JefferiesCigna downgraded to Hold from Buy at Jefferies

Parker Snure

Raymond James

$6,545.73→$5,984.66

Buy

24.81%

Upside

Reiterated

08/03/26

Cigna downgraded to Outperform from Strong Buy at Raymond JamesCigna downgraded to Outperform from Strong Buy at Raymond James

Scott Fidel

Goldman Sachs

$6,358.71→$6,583.13

Buy

37.29%

Upside

Reiterated

08/02/26

Analysts Conflicted on These Healthcare Names: AbbVie (NYSE: ABBV), HealthStream (NASDAQ: HSTM) and Cigna (NYSE: CI)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

IMUXImmunic

ESTAEstablishment Labs Holdings

IRTCIrhythm Technologies

ZYMEZymeworks

ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

3 Months

Ann HynesMizuho Securities

Success Rate

17/27 ratings generated profit

Average Return

+4.54%

Copying Ann Hynes's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +4.54% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

25/32 ratings generated profit

Average Return

+17.73%

Copying Scott Fidel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +17.73% per trade.

2 Years

Scott FidelGoldman Sachs

Success Rate

30/32 ratings generated profit

Average Return

+25.19%

Copying Scott Fidel's trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +25.19% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CI has received 18 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 6,337.93.

Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $140.52 with a range of $138.63 to $145.75. The previous quarter’s EPS was $145.36. CI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $1.36T with a range of $1.32T to $1.39T. The previous quarter’s sales results were $1.34T. CI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year CI has Performed in-line its overall industry.

CI Stock Forecast FAQ

What is MX:CI’s average 12-month price target, according to analysts?

Based on analyst ratings, Cigna Corp’s 12-month average price target is 6,337.93.

What is MX:CI’s upside potential, based on the analysts’ average price target?

Cigna Corp has 32.18% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cigna Corp a Buy, Sell or Hold?

Cigna Corp has a consensus rating of Moderate Buy, which is based on 13 buy ratings, 6 hold ratings and 0 sell ratings.

What is Cigna Corp’s share price target?

The average share price target for Cigna Corp is 6,337.93. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $7,237.70 ,and the lowest forecast is $5,423.60. The average share price target represents 32.18% Increase from the current price of $4,795.

What do analysts say about Cigna Corp?

Cigna Corp’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of Cigna Corp?

To buy shares of MX:CI, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Cigna (CI) Stock Forecast & Price Target

CI Analyst Ratings

CI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cigna

CI Analyst Recommendation Trends

CI Financial Forecast

CI Earnings Forecast

CI Sales Forecast

CI Stock Forecast FAQ

Detailed List of Analyst Forecasts